Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nourish lungs and strengthen spleen granules (also known as Bu Fei Jian Pi granules) is a Traditional Chinese Medicine (TCM) formulation developed by The First Affiliated Hospital of Henan University of Chinese Medicine. It is primarily indicated for the treatment of chronic obstructive pulmonary disease (COPD), specifically for patients categorized under the TCM syndrome of lung-spleen qi deficiency. The therapy aims to improve respiratory symptoms, enhance physical function, and potentially modulate brain metabolic changes associated with chronic respiratory distress. It has been evaluated in clinical trials using MRI and MRS to assess its impact on brain function and clinical outcomes in severe COPD patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bu fei jian pi granules.